{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:01:17Z","timestamp":1787223677032,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-022-05117-0","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T06:03:30Z","timestamp":1652076210000},"page":"1751-1766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2651-1509","authenticated-orcid":false,"given":"Keisuke","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4007-1589","authenticated-orcid":false,"given":"Mitsumasa","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0293-8911","authenticated-orcid":false,"given":"Gautam A.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3082-1374","authenticated-orcid":false,"given":"Sho","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-036X","authenticated-orcid":false,"given":"Satoshi","family":"Kawaai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-5918","authenticated-orcid":false,"given":"Haruki","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-2370","authenticated-orcid":false,"given":"Minoru","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5612-043X","authenticated-orcid":false,"given":"Valeria Rios","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4306-033X","authenticated-orcid":false,"given":"Fabian","family":"Proft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6450-1993","authenticated-orcid":false,"given":"Kurisu","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-2954","authenticated-orcid":false,"given":"Naoto","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-7790","authenticated-orcid":false,"given":"Yoshinori","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4330-5782","authenticated-orcid":false,"given":"Hideto","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4172-8730","authenticated-orcid":false,"given":"Shigeyoshi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-5765","authenticated-orcid":false,"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2944-5583","authenticated-orcid":false,"given":"Hiroaki","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8849-9824","authenticated-orcid":false,"given":"Tadashi","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-9123","authenticated-orcid":false,"given":"Yoichiro","family":"Haji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-3754","authenticated-orcid":false,"given":"Akimichi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0357-0127","authenticated-orcid":false,"given":"Masato","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2047-4900","authenticated-orcid":false,"given":"Yoshinori","family":"Komagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-5837","authenticated-orcid":false,"given":"Clementina L\u00f3pez","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-1986","authenticated-orcid":false,"given":"Anna","family":"Molto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-6229","authenticated-orcid":false,"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1178-3536","authenticated-orcid":false,"given":"Tadakazu","family":"Hisamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5291-7185","authenticated-orcid":false,"given":"Tetsuya","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-180X","authenticated-orcid":false,"given":"Shinya","family":"Kaname","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"5117_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-020-0454-9","volume":"16","author":"E Gracey","year":"2020","unstructured":"Gracey E, Vereecke L, McGovern D et al (2020) Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis. Nat Rev Rheumatol 16:415\u2013433. https:\/\/doi.org\/10.1038\/s41584-020-0454-9","journal-title":"Nat Rev Rheumatol"},{"key":"5117_CR2","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","volume":"75","author":"A Molt\u00f3","year":"2016","unstructured":"Molt\u00f3 A, Etcheto A, van der Heijde D et al (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75:1016\u20131023. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208174","journal-title":"Ann Rheum Dis"},{"key":"5117_CR3","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769\u20132778. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"5117_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","volume":"72","author":"L Van Praet","year":"2013","unstructured":"Van Praet L, Van den Bosch FE, Jacques P et al (2013) Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 72:414\u2013417. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202135","journal-title":"Ann Rheum Dis"},{"key":"5117_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.autrev.2013.06.006","volume":"13","author":"F Atzeni","year":"2014","unstructured":"Atzeni F, Defendenti C, Ditto MC et al (2014) Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev 13:20\u201323. https:\/\/doi.org\/10.1016\/j.autrev.2013.06.006","journal-title":"Autoimmun Rev"},{"key":"5117_CR6","doi-asserted-by":"publisher","first-page":"e0211554","DOI":"10.1371\/journal.pone.0211554","volume":"14","author":"A Hiller","year":"2019","unstructured":"Hiller A, Biedermann L, Fournier N et al (2019) The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort. PLoS One 14:e0211554. https:\/\/doi.org\/10.1371\/journal.pone.0211554","journal-title":"PLoS One"},{"key":"5117_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/ecco-jcc\/jjw199","volume":"11","author":"MC Karreman","year":"2017","unstructured":"Karreman MC, Luime JJ, Hazes JMW, Weel AEAM (2017) The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 11:631\u2013642. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw199","journal-title":"J Crohns Colitis"},{"key":"5117_CR8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/annrheumdis-2013-203854","volume":"73","author":"L Van Praet","year":"2014","unstructured":"Van Praet L, Jans L, Carron P et al (2014) Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort. Ann Rheum Dis 73:1186\u20131189. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203854","journal-title":"Ann Rheum Dis"},{"key":"5117_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/rheumatology\/keu388","volume":"54","author":"I Essers","year":"2015","unstructured":"Essers I, Ramiro S, Stolwijk C et al (2015) Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS. Rheumatology (Oxford) 54:633\u2013640. https:\/\/doi.org\/10.1093\/rheumatology\/keu388","journal-title":"Rheumatology (Oxford)"},{"key":"5117_CR10","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.semarthrit.2021.04.018","volume":"51","author":"D Benavent","year":"2021","unstructured":"Benavent D, Plasencia C, Poddubnyy D et al (2021) Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study. Semin Arthritis Rheum 51:766\u2013774. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.018","journal-title":"Semin Arthritis Rheum"},{"key":"5117_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.semarthrit.2021.06.006","volume":"51","author":"D Poddubnyy","year":"2021","unstructured":"Poddubnyy D, Jadon DR, Van den Bosch F, Mease PJ, Gladman DD (2021) Axial involvement in psoriatic arthritis: an update for rheumatologists. Semin Arthritis Rheum 51:880\u2013887. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.006","journal-title":"Semin Arthritis Rheum"},{"key":"5117_CR12","doi-asserted-by":"publisher","first-page":"e001450","DOI":"10.1136\/rmdopen-2020-001450","volume":"7","author":"C L\u00f3pez-Medina","year":"2021","unstructured":"L\u00f3pez-Medina C, Molto A, Sieper J et al (2021) Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open 7:e001450. https:\/\/doi.org\/10.1136\/rmdopen-2020-001450","journal-title":"RMD Open"},{"key":"5117_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"key":"5117_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645","journal-title":"Ann Rheum Dis"},{"key":"5117_CR15","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"key":"5117_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landew\u00e9 R, Sieper J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18\u201324. https:\/\/doi.org\/10.1136\/ard.2008.094870","journal-title":"Ann Rheum Dis"},{"key":"5117_CR17","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"5117_CR18","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"5117_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/annrheumdis-2017-212076","volume":"77","author":"U Kiltz","year":"2018","unstructured":"Kiltz U, van der Heijde D, Boonen A et al (2018) Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann Rheum Dis 77:1311\u20131317. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212076","journal-title":"Ann Rheum Dis"},{"key":"5117_CR20","unstructured":"Kazuki Y, Alexander B, Jonathan JC, et al (2021) Package \u2018tableone\u2019. Available from: https:\/\/cran.r-project.org\/web\/packages\/tableone\/. Accessed 25 July 2021"},{"key":"5117_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"5117_CR22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.gastro.2018.06.043","volume":"155","author":"SC Shah","year":"2018","unstructured":"Shah SC, Khalili H, Gower-Rousseau C et al (2018) Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from western countries. Gastroenterology 155:1079\u20131089. https:\/\/doi.org\/10.1053\/j.gastro.2018.06.043","journal-title":"Gastroenterology"},{"key":"5117_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3899\/jrheum.200364","volume":"48","author":"D Benfaremo","year":"2021","unstructured":"Benfaremo D, Luchetti MM, Di Carlo M et al (2021) Multicenter validation of the DETAIL Questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases. J Rheumatol 48:179\u2013187. https:\/\/doi.org\/10.3899\/jrheum.200364","journal-title":"J Rheumatol"},{"key":"5117_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13075-018-1724-7","volume":"20","author":"M Ar\u00e9valo","year":"2018","unstructured":"Ar\u00e9valo M, Gratac\u00f3s Masmitj\u00e0 J, Moreno M et al (2018) Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database. Arthritis Res Ther 20:221. https:\/\/doi.org\/10.1186\/s13075-018-1724-7","journal-title":"Arthritis Res Ther"},{"key":"5117_CR25","doi-asserted-by":"publisher","first-page":"e001206","DOI":"10.1136\/rmdopen-2020-001206","volume":"6","author":"MH Derakhshan","year":"2020","unstructured":"Derakhshan MH, Dean L, Jones GT, Siebert S, Gaffney K (2020) Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis. RMD Open 6:e001206. https:\/\/doi.org\/10.1136\/rmdopen-2020-001206","journal-title":"RMD Open"},{"key":"5117_CR26","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/art.40551","volume":"70","author":"G Varkas","year":"2018","unstructured":"Varkas G, Vastesaeger N, Cypers H et al (2018) Association of inflammatory bowel disease and acute anterior uveitis, but not psoriasis, with disease duration in patients with axial spondyloarthritis: results from two Belgian Nationwide Axial Spondyloarthritis Cohorts. Arthritis Rheumatol 70:1588\u20131596. https:\/\/doi.org\/10.1002\/art.40551","journal-title":"Arthritis Rheumatol"},{"key":"5117_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gut.42.3.387","volume":"42","author":"TR Orchard","year":"1998","unstructured":"Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387\u2013391. https:\/\/doi.org\/10.1136\/gut.42.3.387","journal-title":"Gut"},{"key":"5117_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102457","volume":"19","author":"A Picchianti-Diamanti","year":"2020","unstructured":"Picchianti-Diamanti A, Lorenzetti R, Chimenti MS et al (2020) Enteropathic spondyloarthritis: Results from a large nationwide database analysis. Autoimmun Rev 19:102457. https:\/\/doi.org\/10.1016\/j.autrev.2019.102457","journal-title":"Autoimmun Rev"},{"key":"5117_CR29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3899\/jrheum.161518","volume":"44","author":"F Cantini","year":"2017","unstructured":"Cantini F, Niccoli L, Nannini C et al (2017) Case-control study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis associated with inflammatory bowel diseases: role of coexistent psoriasis. J Rheumatol 44:1341\u20131346. https:\/\/doi.org\/10.3899\/jrheum.161518","journal-title":"J Rheumatol"},{"key":"5117_CR30","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/annrheumdis-2012-202143","volume":"72","author":"WQ Li","year":"2013","unstructured":"Li WQ, Han JL, Chan AT, Qureshi AA (2013) Psoriasis, psoriatic arthritis and increased risk of incident Crohn\u2019s disease in US women. Ann Rheum Dis 72:1200\u20131205. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202143","journal-title":"Ann Rheum Dis"},{"key":"5117_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/s1542-3565(05)00980-8","volume":"4","author":"K Takeuchi","year":"2006","unstructured":"Takeuchi K, Smale S, Premchand P et al (2006) Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 4:196\u2013202. https:\/\/doi.org\/10.1016\/s1542-3565(05)00980-8","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5117_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","volume":"50","author":"MD Long","year":"2016","unstructured":"Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS (2016) Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease. J Clin Gastroenterol 50:152\u2013156. https:\/\/doi.org\/10.1097\/MCG.0000000000000421","journal-title":"J Clin Gastroenterol"},{"key":"5117_CR33","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.autrev.2014.04.003","volume":"13","author":"I Olivieri","year":"2014","unstructured":"Olivieri I, Cantini F, Castiglione F et al (2014) Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev 13:822\u2013830. https:\/\/doi.org\/10.1016\/j.autrev.2014.04.003","journal-title":"Autoimmun Rev"},{"key":"5117_CR34","doi-asserted-by":"publisher","first-page":"CD003459","DOI":"10.1002\/14651858.CD003459.pub4","volume":"2014","author":"JW McDonald","year":"2014","unstructured":"McDonald JW, Wang Y, Tsoulis DJ, MacDonald JK, Feagan BG (2014) Methotrexate for induction of remission in refractory Crohn\u2019s disease. Cochrane Database Syst Rev 2014:CD003459. https:\/\/doi.org\/10.1002\/14651858.CD003459.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"5117_CR35","doi-asserted-by":"publisher","first-page":"CD006618","DOI":"10.1002\/14651858.CD006618.pub3","volume":"2014","author":"N Chande","year":"2014","unstructured":"Chande N, MacDonald JK, McDonald JW (2014) Methotrexate for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2014:CD006618. https:\/\/doi.org\/10.1002\/14651858.CD006618.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"5117_CR36","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber W, Sands BE, Lewitzky S et al (2012) Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61:1693\u20131700. https:\/\/doi.org\/10.1136\/gutjnl-2011-301668","journal-title":"Gut"},{"key":"5117_CR37","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/ajg.2016.298","volume":"111","author":"SR Targan","year":"2016","unstructured":"Targan SR, Feagan B, Vermeire S et al (2016) A randomized, double-blind, placebo-controlled phase 2 study of Brodalumab in patients with moderate-to-severe Crohn\u2019s disease. Am J Gastroenterol 111:1599\u20131607. https:\/\/doi.org\/10.1038\/ajg.2016.298","journal-title":"Am J Gastroenterol"},{"key":"5117_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/art.41923","author":"L Penso","year":"2021","unstructured":"Penso L, Bergqvist C, Meyer A et al (2021) Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors: a nationwide population-based study using the French national health data system. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.41923","journal-title":"Arthritis Rheumatol"},{"key":"5117_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.601518","volume":"12","author":"CG Kavadichanda","year":"2021","unstructured":"Kavadichanda CG, Geng J, Bulusu SN, Negi VS, Raghavan M (2021) Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B(*)27 Connection. Front Immunol 12:601518. https:\/\/doi.org\/10.3389\/fimmu.2021.601518","journal-title":"Front Immunol"},{"key":"5117_CR40","first-page":"2860","volume":"27","author":"K de Vlam","year":"2000","unstructured":"de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860\u20132865","journal-title":"J Rheumatol"},{"key":"5117_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-2036.2008.03868.x","volume":"29","author":"TR Orchard","year":"2009","unstructured":"Orchard TR, Holt H, Bradbury L et al (2009) The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn\u2019s disease. Aliment Pharmacol Ther 29:193\u2013197. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03868.x","journal-title":"Aliment Pharmacol Ther"},{"key":"5117_CR42","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3899\/jrheum.180412","volume":"46","author":"M Kishimoto","year":"2019","unstructured":"Kishimoto M, Yoshida K, Ichikawa N et al (2019) Clinical characteristics of patients with spondyloarthritis in Japan in comparison with other regions of the world. J Rheumatol 46:896\u2013903. https:\/\/doi.org\/10.3899\/jrheum.180412","journal-title":"J Rheumatol"},{"key":"5117_CR43","doi-asserted-by":"publisher","first-page":"e001752","DOI":"10.1136\/rmdopen-2021-001752","volume":"7","author":"M Kishimoto","year":"2021","unstructured":"Kishimoto M, Ono K, Fukui S et al (2021) Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study. RMD Open 7:e001752. https:\/\/doi.org\/10.1136\/rmdopen-2021-001752","journal-title":"RMD Open"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05117-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05117-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05117-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T06:05:00Z","timestamp":1662098700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05117-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["5117"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05117-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mitsumasa Kishimoto received consulting fees and\/or speaker fees from AbbVie, Amgen-Astellas BioPharma, Asahi-Kasei Pharma, Astellas, Ayumi Pharma, BMS, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Kyowa Kirin, Novartis, Ono Pharma, Pfizer, Tanabe-Mitsubishi, Teijin Pharma, and UCB Pharma. Minoru Matsuura received consulting and lecture fees from Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd., AbbVie GK, Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co., Ltd., JIMRO Co., Nippon Kayaku Co. Ltd., Mylan EPD G.K., and Aspen Japan Co. Ltd. Fabian Proft reports grants and personal fees from Novartis, grants and personal fees from Lilly, grants and personal fees from UCB, personal fees from AbbVie, personal fees from AMGEN, personal fees from BMS, personal fees from Hexal, personal fees from MSD, personal fees from Pfizer, personal fees from Roche. Naoto Tamura has received speaker fees and\/or consulting fees from AbbVie, Astellas, Bristol-Myers, Squibb, Eisai, Eli Lilly, Janssen, Kyowa Kirin, Mitsubishi-Tanabe and Novartis.Yoshinori Taniguchi has received speaker fees and\/or consulting fees from AbbVie, Eli-Lilly, Janssen, Kyowa Kirin, and Novartis. Hideto Kameda has received consulting fees, speaking fees and\/or honoraria from AbbVie G.K., Asahi Kasei Pharma Co., Ltd, Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd, Eli Lilly Japan K.K., Gilead Sciences Inc., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma, Novartis Pharma K.K., Pfizer Inc., and Sanofi K.K. and has received research grants from AbbVie G.K., Asahi Kasei Pharma Co., Ltd, Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd, Eisai Co., Ltd, and Mitsubishi Tanabe Pharma. Akimichi Morita has received research grants, consulting fees, and\/or speaker\u2019s fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb,Celgene, Eli Lilly, Eisai, Janssen, Kyowa Hakko Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe, Nichi-Iko, Nippon Kayaku, Novartis, Pfizer, Sun Pharmaceutical Industries Taiho Pharmaceutical, and Torii Pharmaceutical, Ushio and UCB Pharma. Masato Okada is a consultant for AbbVie, Eli Lilly, and is on the speaker\u2019s bureau of AbbVie Japan, Eli Lilly and Company, and Ono Pharmaceutical. Clementina L\u00f3pez Medina received consulting fees and\/or honoraria from Lilly, UCB, Abbvie, Janssen and Novartis. Tadakazu Hisamatsu has joint research with Alfresa Pharma Co., Ltd. and EA pharma Co., Ltd. and received grant support from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, JIMRO Co., Ltd., Zeria Pharmaceutical Co., Ltd., Daiichi-Sankyo, Kyorin Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., and Mochida Pharmaceutical Co., Ltd. and received consulting and lecture fees from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, Celgene K.K., EA Pharma Co., Ltd., Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Pfizer Inc. All other authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was conducted according to the guidelines for Good Clinical Practice and was approved by the ethical committees in all countries. Written informed consent was obtained from all subjects before enrolment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}